BioSpace News Archive

Haichao Wang, PhD, one of The Feinstein Institutes for Medical Research’s leading inflammation and sepsis researchers, has earned the Shock Society’s 2021 Scientific Achievement Award for his years of commitment toward sepsis research and significant contributions to the Society.

Trial designed to investigate the cardioprotective properties of CardiolRx(TM) in patients hospitalized with COVID-19 who have a prior history of, or risk factors for, cardiovascular disease

NVG-291 Demonstrated to be Well Tolerated Along with a Favorable Pharmacokinetic Profile.

Alphageneron Pharmaceuticals, Inc. announces the successful completion of a pre-IND (“Investigational New Drug”) meeting with the U.S. Food and Drug Administration (“FDA”)

Prime Therapeutics today introduced IntegratedRx™ - Oncology. This new clinically integrated program streamlines the treatment pathway for members who are fighting cancer so they can now receive their oral oncolytic and companion medications in the clinical setting directly from their oncologist’s clinic or affiliated hospital pharmacy.

Phase Genomics leverages its proprietary ultra-long-range sequencing technology in release of new RUO platform: the first high-resolution, low-cost solution to detect chromosome abnormalities

Pharnext SA today announces the publication of the data from the Company’s first phase III placebo-controlled clinical study of PXT3003 in Charcot-Marie-Tooth disease Type 1A (‘CMT1A’)

The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2021 of $0.85 per share on outstanding common stock.

BIOMODEX has announced the launch of Thrombotech™, a new hydrogel-based synthetic clot product that can be used for neurovascular training using EVIAS Plus™ - Biomodex’s innovative training solution for the treatment of ischemic stroke.

Angion Biomedica Corp today announced it will be presenting four posters at the American Society of Nephrology’s Kidney Week 2021 virtual meeting to be held November 4-7, 2021.